Sinopharm Group Co. Ltd. (SHTDY) Financials
SHTDY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 59.5 billion | 39.5 billion |
| Dec. 31, 2025 | 55.8 billion | 36.6 billion |
| June 30, 2025 | 58.6 billion | 40.6 billion |
| Dec. 31, 2024 | 53.8 billion | 36.5 billion |
SHTDY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| Dec. 31, 2025 | 6.8 billion | ? |
| June 30, 2025 | -4.9 billion | ? |
| Dec. 31, 2024 | 7.0 billion | ? |
SHTDY Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | 501.0 million |
| Dec. 31, 2025 | 1.6 billion |
| June 30, 2025 | 482.6 million |
| Dec. 31, 2024 | 458.4 million |
SHTDY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 6.2 billion | 620.6 million | 539.1 million |
| Dec. 31, 2025 | 8.8 billion | 521.4 million | 571.1 million |
| June 30, 2025 | 6.6 billion | 619.1 million | 635.4 million |
| Dec. 31, 2024 | 7.4 billion | 1.2 billion | 687.7 million |
SHTDY Shares Outstanding
SHTDY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | - | 1.5 billion | - |
| Dec. 31, 2025 | 135.3 million | - | 1.7 billion | - |
| June 30, 2025 | 93.6 million | 17.2 million | 1.7 billion | 1.1 billion |
| Dec. 31, 2024 | 196.9 million | - | 1.8 billion | 1.2 billion |
SHTDY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 41.2 billion | 38.4 billion |
| Dec. 31, 2025 | 40.6 billion | 37.6 billion |
| June 30, 2025 | 39.9 billion | 37.0 billion |
| Dec. 31, 2024 | 39.7 billion | 36.6 billion |
SHTDY
Price: $9.88
Dividend Yield: 5.37%
Forward Dividend Yield: 4.04%
Payout Ratio: 30.98%
Dividend Per Share: 0.39 USD
Earnings Per Share: 1.69 USD
P/E Ratio: 5.86
Exchange: PNK
Sector: Healthcare
Industry: Medical Distribution
Market Capitalization: 5.8 billion
Average Dividend Frequency: 1
Years Paying Dividends: 11
DGR3: 1.61%
DGR5: -8.07%